CD226 and neoplasm: CD226-deficient mice presented increased tumor development and mortality after transplantation of Meth A, 3-methylcholanthrene (MCA)-induced fibrosarcoma, 7,12-dimethylbenz[a]anthracene (DMBA)-induced papilloma tumor cells or CT2610,66.